Replies to post #3523 on XOMA Corporation (XOMA)

[atlas101]

Woops - I have to read this over a few times and talk to a couple other folks - but this looks like a great tool - thanks for sharing it.

[atlas101]

By the way, were the heck have you been?

[atlas101]

One more question - you noted the following quote

In the trial note that even though 20 patients were added the unblinding occured with "approximately one-half the number of patients ORIGINALLY targeted for enrollment."

If they unblinded the data wouldn't they have had an early read at that point weather it was even worth it to continue the study and bother with enrolling more patients?